Walder Wyss advised Engimmune Therapeutics on the deal. Vischer advised the investors Pureos Bio-ventures and Novo Holdings. Engimmune Therapeutics completed a CHF 15.5m seed financing round co-led...
You must be a Standard 1 Year member to access this content.
Vischer advised GlycoEra AG on the deal. Walder Wyss advised 5AM Ventures, Roche Venture Fund and Sofinnova Partners as lead investors. GlycoEra AG has closed CHF...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Ringier Axel Springer Schweiz on the deal. Ringier Axel Springer Schweiz AG (“RASCH”) acquired GRYPS Offertenportal AG from its founders and further shareholders....
You must be a Standard 1 Year member to access this content.
